These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23050958)

  • 1. Cancer prevention as biomodulation: targeting the initiating stimulus and secondary adaptations.
    Furth PA
    Ann N Y Acad Sci; 2012 Oct; 1271(1):1-9. PubMed ID: 23050958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hallmarks of premalignant conditions: a molecular basis for cancer prevention.
    Ryan BM; Faupel-Badger JM
    Semin Oncol; 2016 Feb; 43(1):22-35. PubMed ID: 26970122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinogenesis of Helicobacter pylori.
    Correa P; Houghton J
    Gastroenterology; 2007 Aug; 133(2):659-72. PubMed ID: 17681184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin proteolysis as a retinoid cancer prevention mechanism.
    Dragnev KH; Freemantle SJ; Spinella MJ; Dmitrovsky E
    Ann N Y Acad Sci; 2001 Dec; 952():13-22. PubMed ID: 11795432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of cancer: protease inhibitors.
    Hocman G
    Int J Biochem; 1992 Sep; 24(9):1365-75. PubMed ID: 1426518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NRF2 and cancer: the good, the bad and the importance of context.
    Sporn MB; Liby KT
    Nat Rev Cancer; 2012 Jul; 12(8):564-71. PubMed ID: 22810811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The convergent development of molecular-targeted drugs for cancer treatment and prevention.
    Lippman SM; Heymach JV
    Clin Cancer Res; 2007 Jul; 13(14):4035-41. PubMed ID: 17634526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoids in cancer chemoprevention.
    Lotan R
    FASEB J; 1996 Jul; 10(9):1031-9. PubMed ID: 8801164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point: Surrogate end point biomarkers are likely to be limited in their usefulness in the development of cancer chemoprevention agents against sporadic cancers.
    Armstrong WB; Taylor TH; Meyskens FL
    Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):589-92. PubMed ID: 12869395
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of aberrant proliferation and induction of apoptosis in pre-neoplastic human mammary epithelial cells by natural phytochemicals.
    Katdare M; Osborne MP; Telang NT
    Oncol Rep; 1998; 5(2):311-5. PubMed ID: 9468547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in cancer chemoprevention. Workshop report.
    IARC Sci Publ; 2001; 154():1-12. PubMed ID: 11220649
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferons in precancer and cancer prevention: where are we?
    Tanneberger S; Hrelia P
    J Interferon Cytokine Res; 1996 May; 16(5):339-46. PubMed ID: 8727073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2: a target for prevention and treatment of esophageal cancer.
    Altorki N
    J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemoprevention of mammary preneoplasia. In vitro effects of a green tea polyphenol.
    Araki R; Inoue S; Osborne MP; Telang NT
    Ann N Y Acad Sci; 1995 Sep; 768():215-22. PubMed ID: 8526351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation and learning of molecular networks as a description of cancer development at the systems-level: potential use in anti-cancer therapies.
    Gyurkó DM; Veres DV; Módos D; Lenti K; Korcsmáros T; Csermely P
    Semin Cancer Biol; 2013 Aug; 23(4):262-9. PubMed ID: 23796463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles for modulation of microRNA signatures in cancer chemoprevention.
    Neelakandan K; Babu P; Nair S
    Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Janus-faced role of SIRT1 in tumorigenesis.
    Song NY; Surh YJ
    Ann N Y Acad Sci; 2012 Oct; 1271(1):10-9. PubMed ID: 23050959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precancerous carcinogenesis of human breast epithelial cells by chronic exposure to benzo[a]pyrene.
    Siriwardhana N; Wang HC
    Mol Carcinog; 2008 May; 47(5):338-48. PubMed ID: 17932946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer: the role of extracellular disease.
    Schwartz L; Balosso J; Baillet F; Brun B; Amman JP; Sasco AJ
    Med Hypotheses; 2002 Apr; 58(4):340-6. PubMed ID: 12027530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.